The global retinal biologics market has experienced remarkable growth, with total revenue reaching USD 22.25 billion in 2022. This growth trajectory is projected to continue, as the market is set to reach an impressive USD 41.92 billion by 2028, fueled by a robust compound annual growth rate (CAGR) of 11.1% during the forecast period from …
Category Archives: Healthcare Trends
Prurigo Nodularis Treatment Market to Reach USD 930.9 Million by 2033 with a 3.0% CAGR
The global prurigo nodularis treatment market is projected to grow steadily, with its valuation expected to rise from US$ 693.3 million in 2023 to US$ 930.9 million by 2033, according to a Future Market Insights report. This growth represents a compound annual growth rate (CAGR) of 3.0% over the forecast period. Increased awareness of rare …
Global DNA Sequencing Services Market Set to Surpass USD 2,080.2 million by 2033 Amid Rising Cancer Cases | FMI
The global DNA sequencing services market is witnessing remarkable growth, with a valuation of USD 945.6 million in 2023 and a projected compound annual growth rate (CAGR) of 8.2% over the next decade. By 2033, the market is expected to reach an impressive valuation of USD 2,080.2 million, driven by increasing demand and advancements in …
Neurotrophic Keratitis Treatment Market to Double in Value, Reaching USD 10 Billion by 2033 at a 7.17% CAGR
The global neurotrophic keratitis treatment market is on a trajectory of substantial growth, with its valuation expected to rise from US$ 5 billion in 2023 to an impressive US$ 10 billion by 2033. This reflects a compound annual growth rate (CAGR) of 7.17% over the forecast period, according to Future Market Insights. The surge in …
Point-of-Care Molecular Diagnostics Market Expected to Reach USD 11.1 Billion by 2033, Growing at a 9.7% CAGR
The point-of-care molecular diagnostics market is predicted to secure a valuation of USD 4.4 billion in 2023 and is rising to USD 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …
Meningococcal Meningitis Treatment Market to Reach USD 283 Million by 2033 at a 4.7% CAGR
The global meningococcal meningitis treatment market is poised for steady growth, with its valuation projected to rise from US$ 170.75 million in 2022 to US$ 283 million by 2033. According to industry analysis, the market is expected to register a compound annual growth rate (CAGR) of 4.7% during the forecast period from 2023 to 2033. …
Global Autoimmune Disease Testing Market Poised for Remarkable Growth, Set to reach USD 15.75 billion by 2033
According to Future Market Insights (FMI), the global autoimmune disease testing market is on a trajectory of robust growth. Estimated at USD 6.07 billion in 2023, the market is projected to expand at a 10% compound annual growth rate (CAGR), reaching an impressive USD 15.75 billion by 2033. This growth is driven by an alarming …
Liver Fibrosis Treatment Market to Surpass USD 46.65 Billion in 2033 at a 11% CAGR
The global liver fibrosis treatment market is set to achieve a remarkable valuation of US$ 16.43 billion in 2023, with projections indicating a robust compound annual growth rate (CAGR) of 11% from 2023 to 2033. This growth reflects the increasing focus on innovative therapies aimed at mitigating the impact of liver fibrosis and cirrhosis, which …
Global Infectious Disease Diagnostics Market Set for Rapid Growth, Projected to Reach USD 43.2 Billion by 2034 a CAGR of 7.2%
The global market for infectious disease diagnostics is on a trajectory of steady growth, projected to reach USD 21.5 billion in 2024 and double by 2034, achieving a projected valuation of USD 43.2 billion. This growth, representing a CAGR of 7.2%, underscores the critical importance of innovative diagnostic solutions amid the rising global burden of …
Global Coagulation Analyzer Market Set for Remarkable Growth: Projected to Reach USD 9.2 Billion by 2034 registering a moderate CAGR of 6.6%
The global coagulation analyzer market is poised for significant growth, with its size expected to increase from USD 4.8 billion in 2024 to USD 9.2 billion by 2034. Over the next decade, a moderate 6.6% CAGR in the adoption of coagulation analyzers is projected to drive this expansion. Blood problems and heart ailments have become noticeably prevalent …